National Bank of Canada FI Has $2.60 Million Position in Bruker Co. (NASDAQ:BRKR)

National Bank of Canada FI reduced its holdings in Bruker Co. (NASDAQ:BRKR - Free Report) by 53.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,281 shares of the medical research company's stock after selling 50,586 shares during the quarter. National Bank of Canada FI's holdings in Bruker were worth $2,599,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the business. Eagle Bay Advisors LLC raised its stake in shares of Bruker by 2,324.1% during the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock valued at $41,000 after purchasing an additional 674 shares in the last quarter. UMB Bank n.a. increased its stake in Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock valued at $53,000 after buying an additional 248 shares during the period. GAMMA Investing LLC raised its position in shares of Bruker by 47.5% during the 4th quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock worth $75,000 after buying an additional 412 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Bruker by 41.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company's stock worth $78,000 after acquiring an additional 390 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of Bruker by 13.5% in the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock valued at $127,000 after acquiring an additional 257 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Remove Ads

Analysts Set New Price Targets

BRKR has been the subject of a number of research analyst reports. Bank of America upped their target price on Bruker from $78.00 to $80.00 and gave the stock a "buy" rating in a research report on Friday, December 13th. Stifel Nicolaus decreased their target price on Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research note on Friday, February 14th. Citigroup dropped their price target on shares of Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday, April 7th. Barclays reduced their price objective on shares of Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, Guggenheim reiterated a "buy" rating on shares of Bruker in a report on Monday, February 24th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $66.50.

Bruker Trading Up 1.8 %

Shares of BRKR stock traded up $0.69 during trading hours on Friday, reaching $38.76. 3,139,890 shares of the stock traded hands, compared to its average volume of 1,467,987. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The firm has a market capitalization of $5.88 billion, a PE ratio of 51.00, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a 1-year low of $34.10 and a 1-year high of $90.03. The business has a fifty day moving average price of $46.16 and a 200 day moving average price of $54.75.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, equities research analysts forecast that Bruker Co. will post 2.69 EPS for the current year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 17th were given a dividend of $0.05 per share. The ex-dividend date was Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a yield of 0.52%. Bruker's payout ratio is presently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.